November 20, 2023 11:09 AM EST
News Briefing

Chiesi’s new li­cens­ing deal with Hais­co; Ox­u­ri­on to file for bank­rupt­cy; Hong Kong CD­MO rais­es $210M

Jaimy Lee

Deputy Editor

Chiesi, Hais­co to de­vel­op res­pi­ra­to­ry treat­ment out­side of Chi­na: The com­pa­nies said Mon­day that they plan to work to­geth­er to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times